Medicamen Biotech Limited — Dividend/Bonus, 30-05-2025: Dividend

Medicamen Biotech has announced a final dividend of Rs. 1 per share (10%) for FY 2024-25, pending shareholder approval at the AGM. The company reported a standalone net profit of Rs. 4.75 Cr and consolidated net profit of Rs. 6.55 Cr, reflecting steady profitability. If approved, shareholders will gain a solid return, supported by clean audit reports confirming reliable financials.